Navigation Links
'Different forms of flowers' continues to fascinate
Date:4/29/2010

Although Charles Darwin is most well-known both for his book "On the Origin of Species" and his theories on natural selection, he once stated, "I do not think anything in my scientific life has given me so much satisfaction as making out the meaning of the structure of these plants." What could be more satisfying than unraveling the mysteries of evolution?

Darwin was referring to his studies of different forms of hermaphroditic flowers that occur in a single species. In "'A case to which no parallel exists': The influence of Darwin's Different Forms of Flowers," published in the May issue of the American Journal of Botany, James Cohen discusses Darwin's pioneering work concerning the complex breeding system known as heterostyly and what scientists have discovered since Darwin's time.

"Heterostyly is one of, if not the most, complex type of breeding system found in flowering plants. The presence of heterostyly affects the morphology, ecology, development, genetics, and evolution of a species. Given the far-reaching effects of the complex breeding system, along with the fact that it appears to have evolved over 40 times independently, it is fascinating to think about the function and evolution of heterostyly," Cohen commented.

In heterostylous species, two or more different forms of flowers with both male (anthers) and female (stigmas) parts exist. The anthers and stigmas are at different heights within each form, with the anthers of one flower at the same height as the stigmas of the other flower.

Darwin stated, "The benefit which heterostyled dimorphic plants derive from the existence of the two forms is sufficiently obvious, namely, the intercrossing of distinct plants being thus ensured. Nothing can be better adapted for this end than the relative positions of the anthers and stigmas in the two forms."

"Darwin, along with many of his contemporaries, understood the importance of outcrossing and not mating with close relatives," Cohen said. "Heterostylous species provide at least two different manners in which not only to outcross, but also to avoid inbreeding. These include the morphology, which encourages outcrossing, and a barrier against fertilization by a plant's own pollen, which discourages inbreeding."

Although the presence of this unique type of breeding system is not common, it is found in many economically important plants. A variety of species, from daffodils to purple loosestrife to buckwheat to cocaine, are heterostylous, so understanding the genetics and ecology of the system could have significant economic implications.

Current research related to heterostyly involves trying to determine the underlying genetics of the breeding system. "Although heterostyly appears to be inherited in a Mendelian manner, the exact genes that control the morphology are, for the most part, still unknown," Cohen commented. "Given recent advances in molecular biology techniques, we should be able to determine the genes responsible for the heterostylous syndrome, and that will provide us with many more questions concerning the evolution, development, and ecology of the breeding system that we will address"


'/>"/>

Contact: Richard Hund
rhund@botany.org
314-577-9557
American Journal of Botany
Source:Eurekalert

Related biology news :

1. Adaptation to parasites drive African fishes along different evolutionary paths
2. Plants can be used to study how and why people respond differently to drugs
3. 454 Sequencing uncovers a genetic basis for different social behaviors in wasp
4. Researchers discover important tool in understanding differentiation in human embryonic stem cells
5. At the root of nutrient limitation, ecosystems are not as different as they seem
6. Mechanism for regulation of growth and differentiation of adult muscle stem cells is revealed
7. Bodily breakdown explained: How cell differentiation patterns suppress somatic evolution
8. Severe asthma may be a different form of the disease
9. Scientist postulates 4 aspects of humaniqueness differentiating human and animal cognition
10. Computation to unravel how genes are regulated and shed light on how cells become different
11. Insects evolved radically different strategy to smell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... According to a new market research report "Emotion Detection ... Voice Recognition), Service, Application Area, End User, And Region - Global Forecast to ... 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a Compound ... ... MarketsandMarkets Logo ...
(Date:12/7/2016)... LONDON , Dec. 7, 2016   Avanade ... most successful Formula One teams in history, exploit biometric ... pit stop performance and maintain the competitive edge against ... in 2016. Avanade has worked with ... a range of biometric data (heart rate, breathing rate, ...
(Date:12/6/2016)... , Dec. 6, 2016  Zimmer Biomet Holdings, Inc. ... has priced an offering of €500.0 million principal amount of ... principal amount of its 2.425% senior unsecured notes due 2026. ... to occur on December 13, 2016, subject to the satisfaction of ... annual basis. The Company intends ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Oregon (PRWEB) , ... December 08, 2016 , ... ... and the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI ... not require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. ... bioprocess media products engineered to radically streamline culture processes, minimize processing time, ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented today ... clinical trial for its lead drug candidate, AC0010, at the World Conference on ... to determine the safety, antitumor activity, and recommended phase II dosage of AC0010 ...
Breaking Biology Technology: